Global Diagnostics Enzyme Market Size study & Forecast, by Type (Polymerases and Nucleases, Carbohydrases, Proteases, Oxidases, and Other Types), by Application (Clinical Chemistry, Molecular Diagnostics, and Other Applications), by End-User (Hospitals, Clinical Laboratories, and Other End-Users), and Regional Analysis, 2022-2029
Global Diagnostics Enzyme Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029.Diagnostic Enzymes are the enzymes that are directly used in determining a variety of chemicals known as diagnostic proteins. The Diagnostics Enzyme market is expanding because of factors such as increasing adoption of enzyme-based diagnostic tests and rising geriatric population.
According to the United Nations' World Ageing Highlight for 2020, there were roughly 727 million individuals worldwide who've been 65 and older, and by 2050, there will be 1.5 billion of them, which could help the market for diagnostic enzymes increase. However, higher sensitivity of enzymes temperature and high cost associated with the production and isolation of the enzyme may halt market growth. Further, the market may be fueled by innovations in diagnostics technologies and rising R&D in biotechnology.
The key regions considered for the Global Diagnostics Enzyme Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to higher funding of the government in the pharmaceutical and healthcare sector. Whereas Latin America is expected to grow significantly during the forecast period, owing to improving its health infrastructure and understanding among the public.
Major market players included in this report are:
Codexis Inc.
Sanofi SA
F Hoffmann-La Roche Ltd
Amano Enzymes Inc.
Aldevron
American Laboratories Inc.
Biocatalysts Ltd
Kaneka Eurogentec
Thermo Fisher Scientific
EKF Diagnostics
Recent Developments in the Market:
In June 2020, Codexis Inc. and Alphazyme LLC entered into a partnership agreement. The main aim of this agreement was to enter into production and co-marketing of the enzymes used in the diagnostics and life sciences market. with this agreement, the company will enhance its geographical presence in the long run.
in May 2020, Co-Diagnostics tested a nucleus based testing-kit, this is owing to proper identification of the COVID-19 cancer cells in the human body. With, this experimentation the company will find out a higher level of transparent and unique solutions to the disease.
Global Diagnostics Enzyme Market Report Scope:
Historical DataCompanies Mentioned
Codexis Inc.
Sanofi SA
F Hoffmann-La Roche Ltd
Amano Enzymes Inc.
Aldevron
American Laboratories Inc.
Biocatalysts Ltd
Kaneka Eurogentec
Thermo Fisher Scientific
EKF Diagnostics
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook